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Abstract: Quantitative structure-toxicity relationship (QSTR) plays an important role in 
toxicity prediction. With the modified method, the quantum chemistry parameters of   
57 benzoic acid compounds were calculated with modified molecular connectivity index 
(MCI) using Visual Basic Program Software, and the QSTR of benzoic acid compounds in 
mice via oral LD50 (acute toxicity) was studied. A model was built to more accurately 
predict the toxicity of benzoic acid compounds in mice via oral LD50: 39 benzoic acid 
compounds were used as a training dataset for building the regression model and 18 others 
as a forecasting dataset to test the prediction ability of the model using SAS 9.0 Program 
Software. The model is LogLD50 = 1.2399 × 
0J
A +2.6911 × 
1J
A – 0.4445 × J
B (R
2 = 0.9860), 
where 
0J
A is zero order connectivity index, 
1J
A is the first order connectivity index and  
JB = 
0J
A × 
1J
A is the cross factor. The model was shown to have a good forecasting ability. 
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1. Introduction  
Benzoic acid compounds are an important organic chemical raw material that are widely used in 
food, medicine, cosmetic, antiseptic, insecticide, dyestuff, etc. For example, benzoic acid is a common 
antiseptic, Aspirin is a famous non-steroid anti-inflammatory drug, Triflusal is a antithrombotic, and 
Chloramben and Dicamba are common pesticides (see Figure 1). Most benzoic acid compounds are 
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toxic and are hardly degraded by microorganism in the natural environment, which may cause serious 
public health and environmental problems.  
Figure 1. Molecular structures of benzoic acid (1), aspirin (2), triflusal (3), chloramben (4) 
and dicamba (5). 
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With the development of synthetic chemistry, combinatorial chemistry and pharmaceutical 
chemistry, millions of new compounds are being synthesized. Classical chemical substance evaluation 
needs a lot of time and is expensive, and the speed of analyzing the toxicity of compounds is less than 
the speed of discovery of new compounds. Nowadays, scientists pay more and more attention to the 
importance of prediction toxicity in the early stage. Quantitative structure-toxicity relationships 
(QSTR) have been efficiently used for the study of toxicity mechanisms of various compounds [1]. 
QSTR plays an important role in toxicity forecasting, which is widely used in the modern studying 
of compounds, since more and more compounds are being found. It is necessary to predict the toxicity 
of compounds accurately and quickly [2–4]. QSTR of benzoic acid compounds with molecular 
connectivity index (MCI) in mice via oral LD50 (acute toxicity, half lethal dose) are not reported. The 
quantitative structure characteristic parameters of 57 benzoic acid compounds were obtained with 
MCI. Values of LD50 for mice in benzoic acid compounds have been collected from various literature 
sources. In this work, the QSTR of benzoic acid compounds in mice via oral LD50 was studied and a 
model was developed to more accurately predict the toxicity of benzoic acid compounds in mice via 
oral LD50. 39 benzoic acid compounds were used as a training dataset for building the regression 
model, and 18 other benzoic acid compounds as a forecasting dataset to test the prediction ability of 
the model. The experimental result analysis showed that 
0J
A, 
1J
A and cross factor J
B were important 
factors affecting the toxicity of benzoic acid compounds (although the toxicity mechanism of 
compounds is not clear yet), where 
0J
A is zero order connectivity index, 
1J
A is the first order 
connectivity index and JB= 
0J
A × 
1J
A is the cross factor.  
2. Research Methods 
In 1975, Milan Randic described a skeletal branching index that correlated with the three physical 
properties of alkenes [5]. The concept was further developed and applied extensively by Kier and Hall
 
[6–8], which led to the molecular connectivity index (MCI). Eventually, Kier and Hall modified the 
connectivity indices to discriminate carbon atoms from other heteroatoms, which introduced the 
valance molecular connectivity index 
mχ
t [9]. The MCI is calculated with the follow formula: 
mχ
t = ∑
Nm
j=1(∏
m+1
i 1/δi)
1/2 (1) Int. J. Mol. Sci. 2010, 11                 
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mχ
t is mth-order MCI, t is the type of sub-graph including path (p), cluster (c), path-cluster (pc), Nm is 
the number of the sub-graph of the same type and order. The abbreviation is δ = σ – h, where σ is the 
count of electrons in σ orbital and h is the count of bonding hydrogen atoms. 
There was no doubt that the MCI was proved to be the one of the most successful and widely used 
descriptors. The MCI has been introduced and used in many studies
 [10–13]. 
From the skeletal branching index of Randic to the connectivity index modified by Kier and Hall, 
the core is the connectivity of atoms, which is from the connectivity δi of upper atom to valence 
connectivity of δiv. The computing method of heteroatom i modified by Kier and Hall is as the 
following formula: 
δiv = (Zi – hi)/(Z – Zi – 1)  (2) 
Z and Zi are the count of extra nuclear electrons and valence electrons, respectively, hi is the count 
of hydrogen atoms combining with heteroatom i. Although Kier et al contributed to the computing 
method of heteroatom i, the method could not discriminate the same heteroatom in different oxidation 
states. More recently, Yu et al improved the method, and redefined the valence connectivity value δ
h
i 
using the following formula [14]: 
δ
h
i = 2 × Z (Zi − hi)[(8 – Ni)
1/Ni][(2ni – 1)
 hi/Ni-1]/ [(mi + Lp)(2ni – 1)]  (3) 
mi is the count of bonding electrons, Z is the count of extra nuclear electrons, ni is maximum first 
quantum number, Zi is the valence electron number, Ni is the count, Lp is the hybridization style of 
heteroatom i, the value as following: sp
3, Lp = 1; sp
2, Lp = -1.8; sp, Lp = 2; if that is the atom itself,  
Lp = 2, mi = 0. 
The program package for calculating the MCI of compounds was compiled by Visual Basic 
Program Software according to the modified formula. In order to predict the toxicity of benzoic acid 
compounds and get the prediction model, the molecular structure of 57 benzoic acid compounds was 
entered into the program package and their MCI were calculated. 39 of them were a training dataset for 
building the multi variance linear regression model (logarithm of LD50 as dependent variable and MCI 
as factor), and 18 of them were predicted samples to test the prediction ability of the model using SAS 
9.0 Program Software. During the process of building the regression model, the cross factor was 
considered into the model. 
3. Results and Discussion 
In what follows, we will present the process of computing MCI, choosing factors of the regression 
model and building the model, as well as testing the model. Firstly, zero order connectivity index 
0J
A 
and first order connectivity index 
1J
A were calculated using the program package. The value of LD50 
was converted to logarithm in order to make all the data in the same order of magnitude and easier to 
statistically analysze and compare. Then, the toxicity data was analyzed in the training dataset as 
regression analysis. Non-intercept stepwise regression was chosen as the statistical method. The 
influencing factors were as follows: zero order connectivity index 
0J
A, first order connectivity index 
1J
A and the cross factor JB= 
0J
A × 
1J
A. These influencing factors were inspected, and the results were  
as below: Int. J. Mol. Sci. 2010, 11                 
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(1) 
0J
A: R-Square = 0.9542 and C(p) = 1.0000 
(2) 
1J
A: R-Square = 0.9560 and C(p) = 1.0000 
(3) J
B: R-Square = 0.8656 and C(p) = 1.0000 
(4) 
0J
A, 
1J
A: R-Square = 0.9560 and C(p) = 0.2565 
(5) 
0J
A, J
B: R-Square = 0.9829 and C(p) = 2.0000 
(6) 
1J
A, J
B: R-Square = 0.9816 and C(p) = 2.0000 
(7) 
0J
A, 
1J
A: J
B:R-Square = 0.9860 and C(p) = 3.0000 
The results show that the groups are fine expect (3) and (4), and correlation coefficient (R
2) showed 
that (7) is the best. It was shown that the regression linearity of (7) is better than other groups. 
Therefore, 
0J
A, 
1J
A and J
B were chosen as the independent variables of the model (see Table 1).  
Table 1. Variable parameter estimation analysis. 
Variable 
parameters 
Standard 
estimate 
Error  Type II SS  F value  Pr > F 
0J
A  1.2399 0.4374 6.6827 8.04 0.0075 
1J
A  2.6911 0.8057 9.2768 11.16  0.0020 
J
B -0.4445  0.0509  63.3327  76.16  <0.0001 
 
Comparing the p value in the table, it was shown that 
0J
A, 
1J
A and J
B had an obvious significant 
influence, and a regression estimated model was built: 
LogLD50 = 1.2399 × 
0J
A +2.6911 × 
1J
A – 0.4445 × J
B (R
2 = 0.9860) 
Obeying the principles that the value of correlation coefficient (R
2) is approximate to 1 and the p 
value is less than 0.01, as well as the numbers of the parameters equal to the test coefficient, we found 
that the linearity of the model is appropriate. The result of residual analysis shows that the fitting of the 
model was good (see Table 2). The distribution of residual is a normal distribution, since the scatter 
plots are almost standing on one line (see Figure 2). 
From analysis of the model, it was known that 
0J
A, 
1J
A and cross factor J
B had great influence on the 
oral toxicity in mice. When 
0J
A and 
1J
A decrease, the value of LD50 increases. And LD50 decreases as 
J
B increases. Since increasing LD50 resulted in lower toxicity, therefore, the model showed that 
0J
A and 
1J
A have a negative correlation to the toxicity of benzoic acid compounds, and J
B has a positive 
correlation to the toxicity of benzoic acid compounds. The ability of regression model with 18 benzoic 
acid compounds was also tested, and the result indicates that the prediction ability of the model is good 
(Table 3). It is shown that these influencing factors indeed had an significant effect on toxicity, and the 
forecasting accuracy of the model becomes higher when introducing the cross factor (J
B). Int. J. Mol. Sci. 2010, 11                 
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Table 2. Building the toxicity prediction regression model of benzoic acid compounds with 
training dataset (39 benzoic acid compounds). 
No. 
Compound CAS  No.  LogLD50 
Std error 
(predicted) 
Residual 
  
Dependent 
variable 
Predicted 
value 
  
1  benzamide  55-21-0 7.056 7.187 0.189  -0.131 
2 4-aminobenzoic  acid 150-13-0  7.955  7.264  0.174  0.691 
3  4-chlorobenzoic  acid  74-11-3 7.065 7.254 0.175  -0.189 
4  3-hydroxybenzoic  acid  99-06-9 7.601 7.236 0.176 0.362 
5 4-bromobenzoic  acid 586-76-5  6.965  7.283  0.172  -0.318 
6  2-iodobenzoic  acid  88-67-5 7.313 7.310 0.170 0.003 
7  amino salicylic acid  65-49-6  8.294  7.334  0.169  0.960 
8 methyl  benzoate  93-58-3 8.111 7.490 0.172 0.621 
9  3-aminobenzoic  acid  99-05-8 8.748 7.264 0.174 1.484 
10  3-methylbenzoic  acid  99-04-7 7.396 7.496 0.151  -0.100 
11  4-hydroxybenzoic  acid  99-96-7 7.696 7.239 0.176 0.457 
12  4-methylbenzoic  acid  99-94-5 7.758 7.496 0.151 0.262 
13 6-methylsalicylic  acid  567-61-3 5.522  7.518 0.155 -1.997 
14 3,5-diiodosalicylic  acid  133-91-5 6.109  7.460 0.170 -1.351 
15  2-acetyloxybenzoic acid (aspirin)  50-78-2 5.522 7.493 0.201  -1.971 
16 2,4,6-triiodobenzoic  acid 2012-31-9 7.170  7.490  0.170  -0.320 
17 3,4,5-triiodobenzoic  acid 2338-20-7 8.434  7.490  0.170  0.944 
18 4-tert-butylbenzoic  acid  98-73-7 6.342 6.617 0.481  -0.274 
19 2-formylbenzoic  acid  119-67-5  8.407  7.411  0.160  0.997 
20  2-hydroxybenzamide  (salicylamide)  65-45-2 5.704 7.306 0.181  -1.603 
21  2-hydroxybenzoic acid (salicylic  acid)  69-72-7 6.174 7.243 0.176  -1.069 
22  2-aminobenzoic acid methyl ester 134-20-3  8.269  7.513  0.196  0.756 
23  2-(acetyl amino)benzoic acid  89-52-1  7.016  7.481  0.405  -0.465 
24 2-amino-3,5-dichlorobenzoic  acid 2789-92-6  7.185  7.412  0.173  -0.227 
25 4-hydroxy-3,5-diiodobenzoic  acid  618-76-8  8.294  7.460  0.170  0.834 
26 3,5-diiodo-4-methoxybenzoic  acid 4253-11-6  6.908  7.484  0.280  -0.576 
27  2,3,6-trichlorobenzoic acid (2,3,6-TBA)  50-31-7 6.422 7.408 0.172  -0.986 
28  2-aminobenzoic acid (anthranilic acid) 118-92-3  7.244  7.268  0.174  -0.024 
29  4-aminobenzoic acid ethyl ester (benzocaine)  94-09-7 7.824 7.437 0.235 0.387 
30  2-hydroxybenzoic acid methyl ester 119-36-8  7.012  7.516  0.747  -0.504 
31  2,5-dihydroxybenzoic acid (gentisic acid)  490-79-9  8.412  7.313  0.171  1.099 
32  5-amino-2-hydroxybenzoic acid (mesalamine)  89-57-6 8.123 7.334 0.169 0.789 
33  3-amino-2,5-dichlorobenzoic acid (chloramben) 133-90-4 8.223  7.412  0.173  0.811 
34  benzoic acid N,N-diethylamide (rebemide) 1696-17-9  6.659  6.495  0.517  0.165 
35 3,6-dichloro-2-methoxybenzoic  acid  (dicamba) 1918-00-9 7.082  7.508  0.263 -0.426 
36  1,4-benzenedicarboxylic acid (terephthalic acid)  100-21-0  8.071  7.469  0.153  0.602 
37  2-hydroxy-5-methylbenzoic acid (p-cresotic  acid)  89-56-5 6.908 7.516 0.156  -0.609 
38  4-hydroxybenzoic acid propyl ester (propylparaben)  94-13-3  8.753  7.062  0.405  1.692 
39  2-hydroxy-3-methylbenzoic acid (hydroxytoluic acid)  83-40-9  6.908  7.518  0.155  -0.610 
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Figure 2. Normal P-P Plot of residual. 
 
Table 3. Toxicity prediction of the regression model with Testing dataset (18 benzoic acid 
compounds). 
No. Compound  CAS  No. 
LogLD50 
Dependent 
variable 
Predicted 
value 
1 benzoic  acid  65-85-0  7.57  7.16 
2 2-benzoylbenzoic  acid  85-52-9  6.68  5.69 
3 2,3,5-triiodobenzoic  acid  88-82-4  6.55  7.49 
4 2-benzoyl-5-chlorobenzoic acid  1147-42-8  6.35  6.16 
5 5-amino-2-benzoylbenzoic acid  2162-57-4  7.44  6.14 
6 2-acetoxy-5-bromobenzoic  acid  1503-53-3  6.48  7.43 
7  4-methylbenzoic acid methyl ester  99-75-2  8.24  7.47 
8 2-hydroxy-3,6-dichlorobenzoic acid  3401-80-7  6.49  7.40 
9  benzoic acid 3-hydroxyphenyl ester  136-36-7  6.68  6.06 
10 6-benzoyl-3-methylbenzoic acid  1147-41-7  6.80  5.28 
11 3,4,5-trihydroxybenzoic  acid propyl ester  121-79-9  7.44  6.78 
12  2-hydroxybenzoic acid 2-methylpropyl ester  87-19-4  8.54  6.33 
13 2-(3-chloro-2-methylphenylamino) benzoic acid  13710-19-5  5.63  4.52 
14 
3-acetylamino-2,4,6-triiodobenzoic acid 
(acetrizoate) 
85-36-9 9.90 7.13 
15 
benzoic acid 2-methylpropyl ester (isobutyl 
benzoate) 
120-50-3 8.48  6.50 
16 
2-(2,3-dimethylphenyl)aminobenzoic acid 
(mefenafic acid) 
61-68-7 6.26 3.29 
17 
2-acetyloxy-4-trifluoromethylbenzoic acid 
(triflusal) 
322-79-2 6.08  6.32 
18 
1,1'-biphenyl-2',4'-difluoro-4-hydroxy-3-
carboxylic acid (diflunisal) 
22494-42-4 6.08  5.87 
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4. Conclusions 
LD50 is a common factor for evaluating compound toxicity, which reflects receptivity of test 
animals, and LD50 values have high reproducibility and stability. In QSTR study, linear regression 
analysis is a widely useful quantization method [15]. In this work, the quantitative parameters were 
calculated with MCI and the toxicity prediction model of benzoic acid compounds was obtained as 
follow. LogLD50=1.2399 × 
0J
A +2.6911 × 
1J
A – 0.4445 × J
B, R-Square = 0.9860. The model has a good 
forecasting ability. 
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